Product Information
PREVALITE PACKET is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $0.8034 per EA under NDC 00245003642. Its NADAC has been published 661 times since Nov 28, 2013.
FDA first approved this application on Feb 22, 1996. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 g/5.5g
Manufacturer
Upsher-Smith Laboratories LLCNDC
00245003642
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CHOLESTYRAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA073263FDA Approved
2/22/1996
TE Code
AB
On Market Since
2/1/1996
Pharmacological Classes
Price Statistics
The NADAC for PREVALITE PACKET has been published 661 times since Nov 28, 2013, and over the history we have for it it has declined 54.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8034 per EA |
|---|---|
| All-time high | $2.1232 (Jul 15, 2015) |
| All-time low | $0.7336 (Apr 17, 2024) |
| 52-week high | $0.9006 |
| 52-week low | $0.7955 |
| Median price | $1.4043 |
| Average price | $1.4490 |
| Largest weekly change | +21.4% (Jun 19, 2024) |
| Weeks tracked | 661 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PREVALITE PACKET?
The current National Average Drug Acquisition Cost (NADAC) for PREVALITE PACKET, manufactured by Upsher-Smith Laboratories LLC, is $0.8034 per EA (NDC 00245003642), effective Aug 19, 2026.
How has the price of PREVALITE PACKET changed over time?
Over the history we have for it, the NADAC for PREVALITE PACKET has declined 54.5%. It has been tracked across 661 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PREVALITE PACKET?
Since Nov 28, 2013, the NADAC for PREVALITE PACKET has ranged from a low of $0.7336 (Apr 17, 2024) to a high of $2.1232 (Jul 15, 2015), with a median of $1.4043 per EA.
Are there cheaper alternatives to PREVALITE PACKET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CHOLESTYRAMINE PACKET, is $0.7724 per EA — about 4% below PREVALITE PACKET.
Who manufactures PREVALITE PACKET?
PREVALITE PACKET (NDC 00245003642) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.